ENXTPA:MEDCLPharmaceuticals
MedinCell R&D Day To Highlight LAI Pipeline And Valuation Gap
MedinCell (ENXTPA:MEDCL) has scheduled an online R&D Day focused on its Long Acting Injectable technologies and development plans.
The event is expected to cover the current drug pipeline, new formulations, and future areas of research.
Management also plans to discuss collaboration opportunities and how these programs fit into MedinCell's broader growth priorities.
MedinCell works on Long Acting Injectable drug delivery, a segment that attracts interest from healthcare companies looking...